Skip to main content
. 2019 Jan 23;17(3):2137–2142. doi: 10.3892/etm.2019.7196

Table IV.

Platelet counts before and after treatment in three groups of patients (×109/liter).

Groups Before treatment After treatment t-test P-value
Rituximab group (n=79) 12.3±1.7 75.3±8.4 65.34 <0.001
Cyclophosphamide group (n=86) 12.6±1.3 62.3±7.0a 64.74 <0.001
Combined therapy group (n=84) 12.5±1.4 92.3±9.8a,b 73.88 <0.001
F-value 0.882 267.9
P-value 0.415 <0.001
a

P<0.05, compared with rituximab group

b

P<0.05, compared with cyclophosphamide group.